NFE2L2 and cancer: In addition, there is mounting evidence showing the oncogenic activation of NRF2 in various malignant processes as a result of gene mutation and/or activation of other oncogenes or signaling pathways governing the transcription or degradation of NRF2, thereby conferring on cancer cells a more reduced intracellular environment [91,92].